Torrent Pharmaceuticals Ltd Analyst Rating
based on 29 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
Based on 29 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹3596.55
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share analysis
Torrent Pharmaceuticals Ltd price forecast by 29 analysts
Upside of16.21%
High
₹4232
Target
₹3596.55
Low
₹2930
Torrent Pharmaceuticals Ltd target price ₹3596.55, a slight upside of 16.21% compared to current price of ₹3101.95. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:25.90%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:59.13%
Forecast
Actual
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹3,076₹3,12852 Week's Low
52 Week's High
₹2,025.7₹3,590.7
| Returns % | |
| 1 Month Return | -8.77 % |
| 3 Month Return | -7.64 % |
| 1 Year Return | + 46.01 % |
| Market Stats | |
| Previous Close | ₹3,094.85 |
| Open | ₹3,095.05 |
| Volume | 1.71L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,04,739.08Cr |
Torrent Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 58.12 |
| PEG Ratio | 4.28 |
| Market Cap | ₹1,04,739.08 Cr |
| P/B Ratio | 12.89 |
| EPS | 48.94 |
| Dividend Yield | 1.08 |
| Sector | Pharmaceuticals |
| ROE | 20.43 |
Torrent Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,04,739.08 Cr | 51.19% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹1,56,649.03 Cr | 47.55% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| HOLD | ₹39,265.62 Cr | 5.72% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹29,375.23 Cr | -0.4% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,18,841.71 Cr | 40.62% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Torrent Pharmaceuticals Ltd Mutual Fund Holdings
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Share Price: ₹3101.95 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹1,04,739.08Cr as of today
Revenue: ₹2,831.00Cr as on September 2024 (Q3 24)
Net Profit: ₹453.00Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Reports Growth Amid Challenges - 18 Nov, 2024
Torrent Pharmaceuticals reported 8.6% y-o-y revenue growth but missed estimates due to reduced insulin sales. Strong domestic formulations and improved EBITDA margins are positive signs. The company aims for net cash positivity by 2025-26 and expects benefits from new launches and chronic therapies.
Torrent Pharma Expands Through Strategic Acquisitions - 05 Nov, 2024
Torrent Pharmaceuticals has significantly expanded its domestic business through multiple acquisitions, spending over $1 billion on companies and brands, enhancing its market position.
Torrent Investments Offloads Significant Stake in Torrent Pharmaceuticals - 31 Oct, 2024
Torrent Investments, a promoter entity, sold a 2.9% stake in Torrent Pharmaceuticals for Rs 3,086 crore through open market transactions, impacting the company's stock dynamics.
Torrent Pharma Stake Sale and Share Price Decline - 30 Oct, 2024
Torrent Pharmaceuticals faced a 4% share price drop after a 3% stake sale by promoters raised Rs 3,087 crore for new ventures. The promoter holding decreased to 68.31%. Despite a 17% profit increase, the stock has declined over three days.
Torrent Pharma Stake Sale and Revenue Growth Reported - 29 Oct, 2024
Torrent Pharmaceuticals announced a 9% revenue growth and a target price of Rs 4,232. Promoters plan to sell up to 2.9% stake via block deals, raising ₹3,000 crore. Shares closed lower amid the news.
Torrent Pharmaceuticals Reports Strong Q2 Financials - 28 Oct, 2024
Torrent Pharmaceuticals achieved a 17.4% increase in Q2 profit to ₹453 crore and an 8.6% revenue growth to ₹2,889 crore, demonstrating resilience in the pharmaceutical sector.
Torrent Pharma Reports Strong Q2 Earnings Growth - 26 Oct, 2024
Torrent Pharmaceuticals reported a 17% YoY increase in Q2 PAT to Rs 453 crore, with revenue rising 8.6% to Rs 2,889 crore. The company's India revenue grew by 13%, driven by strong performance in chronic therapies. Shares rallied 3.63% to Rs 3,436.65 on the BSE.
Torrent Pharma Reports Profit Rise, Misses Estimates - 25 Oct, 2024
Torrent Pharmaceuticals announced a 17.4% increase in net profit to Rs 453 crore for Q2 FY25, but fell short of analyst expectations due to an insulin facility shutdown. The company anticipates recovering the shortfall in Q4, with strong domestic sales driving overall growth.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 14.22% to 14.46% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 5.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.25% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 12.5%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.26% to 7.21% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 4.35% to 3.69% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.88K Cr → 2.87K Cr (in ₹), with an average decrease of 0.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, TORNTPHARM stock has moved down by -8.8%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 457.0 Cr → 453.0 Cr (in ₹), with an average decrease of 0.9% per quarter
Torrent Pharmaceuticals Ltd Financials
Index Inclusions
Torrent Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.25% | 0.00 | |
| Foreign Institutions | 14.46% | 1.68 | |
| Mutual Funds | 3.69% | ||
| Retail Investors | 7.21% | ||
| Others | 3.4% | 16.12 |
Torrent Pharmaceuticals Ltd Key Indicators
Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (54.42x)
November 19, 2024
Today (58.12x)
November 19, 2024
Highest (73.85x)
April 3, 2019
Torrent Pharmaceuticals Ltd Earnings and Dividends
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 17.36% since last year same period to ₹453Cr in the Q2 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated -0.88% fall in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹6 - translating a dividend yield of 1.16%.
Read More about Dividends
Torrent Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Torrent Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Torrent Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Torrent Pharmaceuticals Ltd shares.
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price today is ₹3101.95
Torrent Pharmaceuticals Ltd is listed on NSE
Torrent Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Torrent Pharmaceuticals Ltd is ₹3128.
- Today’s lowest price of Torrent Pharmaceuticals Ltd is ₹3076.
PE Ratio of Torrent Pharmaceuticals Ltd is 58.12
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 1.71L.
Today’s market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹104739.08Cr.
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Price |
|---|---|
52 Week High | ₹3590.7 |
52 Week Low | ₹2025.7 |
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3101.95. It is down -13.61% from its 52 Week High price of ₹3590.7
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3101.95. It is up 53.13% from its 52 Week Low price of ₹2025.7
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Returns |
|---|---|
1 Day Returns | 7.1% |
1 Month Returns | -8.77% |
3 Month Returns | -7.64% |
1 Year Returns | 46.01% |